• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.70% Nasdaq Down 0.47%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.48 Down 0.03(0.67%) 11:08AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.51
    Open:4.54
    Bid:4.42 x 8300
    Ask:4.43 x 4400
    1y Target Est:7.67
    Beta:-4.31
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:4.41 - 4.66
    52wk Range:3.26 - 7.36
    Volume:881,559
    Avg Vol (3m):8,111,350
    Market Cap:986.11M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 0.67%986.11M
    GSKDown 1.81%106.60B
    OREXDown 1.50%649.07M
    RHHBYDown 1.35%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.93

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback